Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) represents a potent therapeutic option in the battle against the virus. This innovative treatment harnesses the power of neutralizing antibodies derived from individuals who have recovered from COVID-19. When administered via intravenous injection, Human Immunoglobulin (pH4) delivers a concentrated dose of these potent antibodies,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian